EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants

Jianbo Wu, Zhenguo Chen, Yidan Gao, Zegen Wang, Jiarong Wang, Bing-Yu Chiang, Yunjiao Zhou, Yuru Han, Wuqiang Zhan, Minxiang Xie, Weiyu Jiang, Xiang Zhang und 10 weitere

Cell Reports · 2023-05 · 42 (5) · 112503

DOI: 10.1016/j.celrep.2023.112503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-05. Verfasst von Jianbo Wu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Cen…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Health Commission, Government of South Australia, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Striking antibody evasion by emerging circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants drives the identification of broadly neutralizing antibodies (bNAbs). However, how a bNAb acquires increased neutralization breadth during antibody evolution is still elusive. Here, we identify a clonally related antibody family from a convalescent individual. One of the members, XG005, exhibits potent and broad neutralizing activities against SARS-CoV-2 variants, while the other members show significant reductions in neutralization breadth and potency, especially against the Omicron sublineages. Structural analysis visualizing the XG005-Omicron spike binding interface reveals how crucial somatic mutations endow XG005 with greater neutralization potency and breadth. A single administration of XG005 with extended half-life, reduced antibody-dependent enhancement (ADE) effect, and increased antibody product quality exhibits a high therapeutic efficacy in BA.2- and BA.5-challenged mice. Our results provide a natural example to show the importance of somatic hypermutation during antibody evolution for SARS-CoV-2 neutralization breadth and potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AnimalsMiceAntibodiesBroadly Neutralizing AntibodiesMutationAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

CP: ImmunologyCP: MicrobiologySARS-CoV-2bNAbbroadly neutralizing antibodyclonally related antibody familysomatic hypermutationvariant of concern

Substanzen

AntibodiesBroadly Neutralizing AntibodiesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Fifth People's Hosp…
  • Advaccine Biopharmaceuticals Suzhou Co., Ltd., Suzhou, China.
  • Fundamental Research Center, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai 201619, China.
  • Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Förderung

  • Guangzhou Municipal Health Commission
  • Government of South Australia
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • Fudan University
  • Science and Technology Commission of Shanghai Municipality
  • National Cancer Institute

Zitieren

APA

Wu, J., Chen, Z., Gao, Y., Wang, Z., Wang, J., Chiang, B. Y., Zhou, Y., Han, Y., Zhan, W., Xie, M., Jiang, W., Zhang, X., Hao, A., Xia, A., He, J., Xue, S., Mayer, C. T., Wu, F., Wang, B., …, & Wang, Q. (2023). Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants. Cell Reports, 42(5), 112503. https://doi.org/10.1016/j.celrep.2023.112503

Vancouver

Wu J, Chen Z, Gao Y, Wang Z, Wang J, Chiang BY, et al. Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants. Cell Reports. 2023;42(5):112503. doi:10.1016/j.celrep.2023.112503

BibTeX
@article{Wu2023,
  author = {Wu, Jianbo and Chen, Zhenguo and Gao, Yidan and Wang, Zegen and Wang, Jiarong and Chiang, Bing-Yu and Zhou, Yunjiao and Han, Yuru and Zhan, Wuqiang and Xie, Minxiang and Jiang, Weiyu and Zhang, Xiang and Hao, Aihua and Xia, Anqi and He, Jiaying and Xue, Song and Mayer, Christian T and Wu, Fan and Wang, Bin and Zhang, Lunan and Sun, Lei and Wang, Qiao},
  title = {Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {5},
  pages = {112503},
  doi = {10.1016/j.celrep.2023.112503}
}
Kostenlos starten →